IgG Antibody Response to Toxins A and B in Patients with Clostridium difficile Infection | Zendy

Marlene Wullt | Zendy; Torbjörn Norén | Zendy; Åsa Ljungh | Zendy; Thomas Åkerlund | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

IgG Antibody Response to Toxins A and B in Patients with Clostridium difficile Infection

Author(s) -

Marlene Wullt,

Torbjörn Norén,

Åsa Ljungh,

Thomas Åkerlund

Publication year - 2012

Publication title -

clinical and vaccine immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.649

H-Index - 77

eISSN - 1556-6811

pISSN - 1556-679X

DOI - 10.1128/cvi.00210-12

Subject(s) - clostridium difficile , clostridium difficile toxin a , antibody , clostridium difficile toxin b , microbiology and biotechnology , toxin , immunology , antibody response , population , medicine , clostridium infections , virology , biology , antibiotics , environmental health

IgG antibodies against Clostridium difficile toxins A and B were followed in controls and in patients with an initial C. difficile infection (CDI). Of the 50 CDI patients, 38 were cured and 12 developed recurrence. Compared to controls, patients had significantly lower anti-toxin A and B IgGs at inclusion, but the subsequent levels rose slightly regardless of clinical outcome. The results imply that the general serum reactivity against toxins A and B in the population reduces the risk of CDI, which suggests implications for vaccine strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research